SHIP1 Inhibition Increases Immunoregulatory Capacity and Triggers Apoptosis of Hematopoietic Cancer Cells
Authors:
- 1 April 2010
- journal article
- Published by Oxford University Press (OUP) in The Journal of Immunology
- Vol. 184 (7) , 3582-3589
Abstract
Genetic studies revealed that SHIP1 limits blood cell production and immune regulatory cell numbers in vivo. We postulated that molecular targeting of SHIP1 might enhance blood cell production and increase immunoregulatory capacity. In this study, we report the identification of a chemical inhibitor of SHIP1, 3 α-aminocholestane (3AC). Treatment with 3AC significantly expands the myeloid immunoregulatory cell compartment and impairs the ability of peripheral lymphoid tissues to prime allogeneic T cell responses. In addition, 3AC treatment profoundly increases granulocyte production without triggering the myeloid-associated lung consolidation observed in SHIP1−/− mice. Moreover, 3AC also enhances RBC, neutrophil, and platelet recovery in myelosuppressed hosts. Intriguingly, we also find that chemical inhibition of SHIP1 triggers apoptosis of blood cancer cells. Thus, SHIP1 inhibitors represent a novel class of small molecules that have the potential to enhance allogeneic transplantation, boost blood cell production, and improve the treatment of hematologic malignancies.Keywords
Funding Information
- National Institutes of Health (RO1 DK54767)
- National Institutes of Health (RO1 HL72523)
This publication has 37 references indexed in Scilit:
- Regulation of PI(3)K/Akt signalling and cellular transformation by inositol polyphosphate 4‐phosphatase‐1EMBO Reports, 2009
- SHIP is required for a functional hematopoietic stem cell nicheBlood, 2009
- SHIP limits immunoregulatory capacity in the T-cell compartmentBlood, 2009
- SH2-Inositol Phosphatase 1 Negatively Influences Early Megakaryocyte ProgenitorsPLOS ONE, 2008
- PI3K pathway alterations in cancer: variations on a themeOncogene, 2008
- Influence of SHIP on the NK Repertoire and Allogeneic Bone Marrow TransplantationScience, 2002
- Embryonic and hematopoietic stem cells express a novel SH2–containing inositol 5′-phosphatase isoform that partners with the Grb2 adapter proteinBlood, 2001
- Differential Regulation of B Cell Development, Activation, and Death by the Src Homology 2 Domain–Containing 5′ Inositol Phosphatase (Ship)Journal of Experimental Medicine, 2000
- Prevention of Graft Versus Host Disease by Inactivation of Host Antigen-Presenting CellsScience, 1999
- Stimulation of mature unprimed CD8+ T cells by semiprofessional antigen-presenting cells in vivo.Journal of Experimental Medicine, 1992